Pilot study investigating proof-of-concept with ACH 1625 in the treatment of HCV genotype 3
Latest Information Update: 13 Mar 2012
Price :
$35 *
At a glance
- Drugs Sovaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 13 Mar 2012 New trial record
- 09 Jan 2012 Status changed from not stated to completed, according to an Achillion Pharmaceuticals media release.